CTNM
Contineum Therapeutics, Inc.
12.70$
+0.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.2% | -5.2% | +79.1% | -2.4% | -1.5% | -6.9% | -7.8% | +4.4% | +45.0% | -5.5% | -4.2% | |
| – | -7.1% | -6.3% | +84.0% | -2.3% | -4.1% | -6.9% | -8.0% | +4.6% | +44.9% | -5.6% | -4.1% | |
| – | -11.4% | +4.8% | +374.9% | -47.1% | -46.3% | +2.4% | -7.5% | +105.1% | +77.3% | -73.3% | -27.0% | |
| – | -7.4% | -5.8% | +85.4% | -2.2% | -4.3% | -6.9% | -8.0% | +3.9% | +44.1% | -6.3% | -4.0% | |
| – | -0.9% | +0.4% | -98.1% | +50.7% | +154.6% | -8.7% | -14.8% | -9.7% | +50.8% | -27.8% | -5.3% | |
| – | -26.3% | +13.7% | -40.0% | +55.3% | +71.8% | -10.3% | -19.4% | -11.8% | +53.2% | -31.7% | -2.0% | |
| – | -58.6% | +2.2% | +2.1% | +26.2% | +137.6% | +0.2% | +0.8% | +0.8% | +58.5% | -1.6% | +3.9% | |
| – | -39.8% | -10.2% | +28.8% | +90.3% | +29.6% | +101.3% | -45.1% | -60.7% | +29.3% | +47.1% | -66.2% | |
| – | – | – | – | -3.3% | -5.8% | -6.7% | -7.2% | +5.3% | +44.6% | -4.2% | -4.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +2.4% | +0.0% | +0.0% | +0.5% | +0.1% | +0.1% | +8.6% | +9.8% | +21.0% | +0.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.